Toshiba Medical Systems, the medical device business Toshiba (TYO:6502) is selling to Canon (NYSE:CAJ) for $6.5 billion, reportedly entered the race to acquire a chemicals subsidiary of Takeda Pharmaceutical (TYO:4502).
The Nikkei business daily reported today that Takeda is looking to sell its 70% stake in Osaka-based Wako Pure Chemicals Industries, with the 1st round of bidding closing August 16.
Toshiba Medical is competing with Hitachi (NYSE:HIT) and Fujifilm Holdings (TSE:4901) to compete for Wako Pure, the Japanese newspaper reported.